Lonigutamab

Lonigutamab · ACELYRIN Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lonigutamab, covering 2025-07-01 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED) [Phase 1, Phase 2]